What
Where
DEVELOP A NEXT-GENERATION, MUCOSALLY DELIVERED, COVID-19 BOOSTER VACCINE CAPABLE OF ELICITING MUCOSAL IMMUNITY AND PROTECTING AGAINST SARS-COV-2 BREAKTHROUGH IN...
From: Federal Procurement Data System(Federal)
 Basic Details |  Start Date30 Sep, 2023 (7 months ago) Due Date02 Aug, 2027 (in about 3 years) TypeContractIdentifierBAA-18-100-SOL-00003 | ||||
 Customer / Agency | OFFICE OF ASSISTANT SECRETARY FOR PREPAREDNESS AND RESPONSE | ||||
Unlock the best of InstantMarkets.Please Sign In to see more out of InstantMarkets such as history, intelligent business alerts and many more.
Don't have an account yet? Create a free account now.
DEVELOP A NEXT-GENERATION, MUCOSALLY DELIVERED, COVID-19 BOOSTER VACCINE CAPABLE OF ELICITING MUCOSAL IMMUNITY AND PROTECTING AGAINST SARS-COV-2 BREAKTHROUGH INFECTION AND TRANSMISSION Solicitation ID/Procurement Identifier: BAA-18-100-SOL-00003 Ultimate Completion Date: Mon Aug 02 17:00:00 GMT
Location
Address: 175 VARICK ST RM 608,NEW YORK,NEW YORK,USA
Country : United StatesYou may also like
OVER THE COUNTER (OTC) COVID-19 TESTS
Due: 19 Mar, 2025 (in 10 months)EO14042 - VACCINE MANDATE FOR COVID19 INFO - KAPPA LAMBA AND HEVY LITE TESTING KITS
Due: 14 Jun, 2025 (in 13 months)OVER THE CONTER (OTC) COVID-19 TESTS
Due: 19 Mar, 2025 (in 10 months)Please Sign In to see more like these.
Don't have an account yet? Create a free account now.